GH1 and amyotrophic lateral sclerosis: In patients affected by ALS, a significant reduction in GH/IGF-1 secretion was found, and the efficacy of GH/IGF-1 treatment in improving muscle force, motor coordination, and protection of motor neurons has been controversial in the clinic [41, 42].